Re-defined Pathways to Cures Roadmap
Updated Roadmap defines current research priorities based on new knowledge of the disease; is endorsed by 30 MS organizations worldwide…
Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis
September 2, 2024 • In the HERCULES study, tolebrutinib met the primary endpoint in delaying time to onset of confirmed…
Stuart Schlossman
Smoldering‐Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions –
Abstract Despite therapeutic suppression of relapses, multiple sclerosis (MS) patients often experience subtle deterioration, which extends beyond the definition of…
Stuart Schlossman
Understanding PIRA in Multiple Sclerosis
Detailed exploration of studies evaluating the use of highly effective treatments have unveiled the clinical concept of Progression Independent of…
Stuart Schlossman
Could CAR T cell therapy change the way we treat autoimmune diseases?
CAR T cell therapy is now being studied in autoimmune diseases, including: The immune system is the body’s natural defense…
Stuart Schlossman
Different lymphocyte counts of ms patients treated with ofatumumab and ocrelizumab
Christoph Friedli 1 2, Nik Krajnc 3 4, Helly N Hammer 1, Stefanie Marti 1, Tobias Zrzavy 3 4, Maria E Evangelopoulos 5, Ioanna Kapsali 5, Paulus Rommer 3 4, Thomas Berger 3 4, Andrew Chan 1, Gabriel Bsteh 3 4, Robert Hoepner 1 Affiliations expand Abstract Introduction: Patients with Multiple…
Stuart Schlossman
Multiple Sclerosis: Can a Blood Test Detect MS Years Before Symptoms Appear? New Research Encouraging
Written By: John Fernandez Published: May 1, 2024 Disponible en Español New clinical trial findings could advance the early treatment for patients…
Stuart Schlossman
‘Liquid gold’ could bring new hope to multiple sclerosis patients, study suggests: ‘Profound benefit’
In Phase 2 trials, drinkable medication with gold nanocrystals significantly reduced symptoms By Melissa Rudy Fox News – Published April 30, 2024 5:30am…
Stuart Schlossman
A Smoldering Process: A New Way of Thinking about Multiple Sclerosis
Published on: October 4, 2023 Our understanding of the biology of multiple sclerosis is changing. New research sheds light on…
Stuart Schlossman
PET scans reveal ‘smoldering’ inflammation in patients with MS
April 26, 2024 A new study suggests positron emission tomography brain scans could reveal hidden inflammation in patients with multiple…
Stuart Schlossman
